Company profile: Albert Labs
1.1 - Company Overview
Company description
- Provider of pharmaceutical drug development services focused on mental health, pursuing regulatory approval for active compounds. Offerings include KRN-101, a natural psilocybin medicine for cancer-related anxiety; psychedelic-assisted therapy training for mental health professionals; and real-world evidence studies to accelerate development and access of mental health medicines.
Products and services
- KRN-101: Natural psilocybin medicine engineered to target cancer-related anxiety, pursuing regulatory approval for an active compound to treat mental health conditions
- Real World Evidence (RWE) Studies: Clinical research approach architected to accelerate the development and access of mental health medicines, supporting Albert Labs' mission to pursue regulatory approval for active therapeutic compounds
- Psychedelic-Assisted Therapy Training: Professional-focused training program that instructs mental health professionals on the use of psychedelic substances in therapy for mental health treatment applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Albert Labs
X-Chem
HQ: United States
Website
- Description: Provider of AI-driven small molecule drug discovery solutions, including ArtemisAI to analyze DEL data and predict new binders; DEL screening services across target classes; medicinal chemistry to convert hits into leads; integrated Dynamic Drug Discovery (XD3); HITMiner to expand binder predictions; and LEADChaser to advance DEL outputs through rapid design-test loops.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full X-Chem company profile →
SDI Health
HQ: United States
Website
- Description: Provider of healthcare market insight and analytics services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SDI Health company profile →
Faro Health
HQ: United States
Website
- Description: Provider of a cloud-based Smart Designer Platform for designing clinical trial protocols, offering real-time performance insights and recommendations for protocol optimization; SOC 2 Type 2 compliant to ensure security, availability, and confidentiality. Member of Microsoft for Startups with access to Microsoft technology, mentorship, and business support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Faro Health company profile →
Sunquest
HQ: United States
Website
- Description: Provider of diagnostic and laboratory information systems for healthcare providers worldwide, serving more than 1,700 laboratories and 300,000 end users. Solutions include Clinisys Clinical Laboratory for complex workflows, Clinisys Blood Bank Management for multi-facility inventory and patient safety, and the Clinisys Platform integrating data and workflows with cloud architecture and analytics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sunquest company profile →
Unlearn
HQ: United States
Website
- Description: Provider of AI, digital twin, and statistical methods to enable smaller, more efficient clinical trials, offering TwinRCTs (RCTs enhanced with AI-generated digital twins), Digital Twin Generators to predict individual health outcomes over time, regulatory services to navigate and meet FDA and EMA guidelines, and PROCOVA using prognostic scores from digital twins to enhance statistical power.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Unlearn company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Albert Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Albert Labs
2.2 - Growth funds investing in similar companies to Albert Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Albert Labs
4.2 - Public trading comparable groups for Albert Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →